Skip to main content
Erschienen in: Molecular Imaging and Biology 4/2020

02.12.2019 | Research Article

The Effect of Chirality on the Application of 5-[18F]Fluoro-Aminosuberic Acid ([18F]FASu) for Oxidative Stress Imaging

verfasst von: Milena Čolović, Hua Yang, Helen Merkens, Nadine Colpo, François Bénard, Paul Schaffer

Erschienen in: Molecular Imaging and Biology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The cystine transporter, system xC-, plays a crucial role in sustaining redox homeostasis and is reported to be overexpressed in several cancer subtypes. 5-[18F]Fluoroaminosuberic acid ([18F]FASu) is a novel positron emission tomography (PET) tracer, which exhibits specific uptake via system xC-. [18F]FASu synthesis by the commonly used Kryptofix 2.2.2/K2CO3-facilitated fluorination method results in four diastereomers, as a result of 2 chiral centers at positions 2- and 5- of the tracer. We recently reported the synthesis of the optically pure 2S-[18F]FASu from chiral precursors. Our preliminary results indicated preferential uptake of the 2S-isomer by tumor cells compared to 2R-[18F]FASu. Few studies have investigated the biodistribution of chiral 18F-labeled amino acids. The aim of this study was to evaluate the imaging utility and biodistribution of the 5-position diastereomers as well as the racemic (2S,5R/S-) mixture in three different tumor models.

Procedures

In vitro tracer uptake experiments and Western blotting were performed in breast cancer (MDA-MB-231), glioblastoma (U-87), and prostate (PC-3) cancer cell lines. PET imaging and biodistribution studies were conducted in xenograft-bearing immunocompromised Rag2M female mice.

Results

All three tracer conformations allowed for the visualization of tumor xenografts at 1 h (for U-87 and PC-3 tumors) or 2 h (in the case of MDA-MB-231 xenografts) post-injection, with the racemate (2S,5R/S-) displaying similar image contrast as compared to the 5- position diastereomers and the 2S,5S-[18F]FASu conformation exhibiting relatively higher contrast for imaging U-87 and PC-3 xenografts. Tumor uptake of the isomers was blocked by an excess of the non-radioactive standard, aminosuberic acid (ASu), confirming target specificity. All three isomers were excreted via the renal pathway. Biodistribution analyses showed that PC-3 tumors had the highest tracer uptake, and the accumulation (%ID/g) of the 2S,5R/S-, 2S,5S-, and 2S,5R- isomers was 9.19 ± 1.14, 8.00 ± 1.41, and 7.16 ± 2.13 at 1 h post-injection, respectively. This gave corresponding tumor-to-muscle ratios of 33.68 ± 9.52, 31.42 ± 4.54, and 25.33 ± 4.97, respectively.

Conclusion

Our data suggest that pure 2S-[18F]FASu can be used to noninvasively image system xC- in a variety of cancers, either as the racemic mixture (2S,5R/S-) or optically pure form. Furthermore, this work shows potential utility of [18F]FASu for detection of glioblastoma and prostate cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Nakanishi T, Tamai I (2011) Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy. J Pharm Sci 100:3731–3750CrossRef Nakanishi T, Tamai I (2011) Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy. J Pharm Sci 100:3731–3750CrossRef
2.
Zurück zum Zitat Timmerman LA, Holton T, Yuneva M et al (2013) Glutamine sensitivity analysis identifies the xCT antiporter as a common triple negative breast tumor therapeutic target. Cancer Cell 24:450–465CrossRef Timmerman LA, Holton T, Yuneva M et al (2013) Glutamine sensitivity analysis identifies the xCT antiporter as a common triple negative breast tumor therapeutic target. Cancer Cell 24:450–465CrossRef
3.
Zurück zum Zitat Ganapathy V, Thangaraju M, Prasad RD (2009) Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond. Pharmacol Ther 121:29–40CrossRef Ganapathy V, Thangaraju M, Prasad RD (2009) Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond. Pharmacol Ther 121:29–40CrossRef
4.
Zurück zum Zitat Wang Q, Holst J (2015) L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Am J Cancer Res 5:1281–1294PubMedPubMedCentral Wang Q, Holst J (2015) L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Am J Cancer Res 5:1281–1294PubMedPubMedCentral
5.
Zurück zum Zitat Altan B, Kaira K, Watanabe A et al (2018) Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma. Cancer Chemother Pharmacol 81:141–153CrossRef Altan B, Kaira K, Watanabe A et al (2018) Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma. Cancer Chemother Pharmacol 81:141–153CrossRef
6.
Zurück zum Zitat Toyoda M, Kaira K, Ohshima Y et al (2014) Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer. Br J Cancer 110:2506–2513CrossRef Toyoda M, Kaira K, Ohshima Y et al (2014) Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer. Br J Cancer 110:2506–2513CrossRef
7.
Zurück zum Zitat Piroth MD, Pinkawa M, Richard H et al (2011) Prognostic value of early [ 18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 80:176–184CrossRef Piroth MD, Pinkawa M, Richard H et al (2011) Prognostic value of early [ 18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 80:176–184CrossRef
8.
Zurück zum Zitat Yanagisawa N, Ichinoe M, Mikami T, Nakada N, Hana K, Koizumi W, Endou H, Okayasu I (2012) High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas. J Clin Pathol 65:1019–1023CrossRef Yanagisawa N, Ichinoe M, Mikami T, Nakada N, Hana K, Koizumi W, Endou H, Okayasu I (2012) High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas. J Clin Pathol 65:1019–1023CrossRef
9.
Zurück zum Zitat McConathy J, Goodman M (2008) Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev 27:555–557CrossRef McConathy J, Goodman M (2008) Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev 27:555–557CrossRef
10.
Zurück zum Zitat Huang C, McConathy J (2013) Radiolabeled amino acids for oncologic imaging. J Nucl Med 54:1007–1010CrossRef Huang C, McConathy J (2013) Radiolabeled amino acids for oncologic imaging. J Nucl Med 54:1007–1010CrossRef
11.
Zurück zum Zitat Qu W, Zha Z, Ploessl K et al (2011) Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc 133:1122–1133CrossRef Qu W, Zha Z, Ploessl K et al (2011) Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc 133:1122–1133CrossRef
12.
Zurück zum Zitat Liu F, Xu X, Zhu H, Zhang Y, Yang J, Zhang L, Li N, Zhu L, Kung HF, Yang Z (2018) PET imaging of 18F-(2S,4R)4-fluoroglutamine accumulation in breast cancer: from xenografts to patients. Mol Pharm 15:3448–3455CrossRef Liu F, Xu X, Zhu H, Zhang Y, Yang J, Zhang L, Li N, Zhu L, Kung HF, Yang Z (2018) PET imaging of 18F-(2S,4R)4-fluoroglutamine accumulation in breast cancer: from xenografts to patients. Mol Pharm 15:3448–3455CrossRef
13.
Zurück zum Zitat Urakami T, Sakai K, Asai T et al (2009) Evaluation of O-[18F]fluoromethyl-d-tyrosine as a radiotracer for tumor imaging with positron emission tomography. Nucl Med Biol 36:295–303CrossRef Urakami T, Sakai K, Asai T et al (2009) Evaluation of O-[18F]fluoromethyl-d-tyrosine as a radiotracer for tumor imaging with positron emission tomography. Nucl Med Biol 36:295–303CrossRef
14.
Zurück zum Zitat Webster JM, Morton CA, Johnson BF et al (2014) Functional Imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid. J Nucl Med 55:657–664CrossRef Webster JM, Morton CA, Johnson BF et al (2014) Functional Imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid. J Nucl Med 55:657–664CrossRef
15.
Zurück zum Zitat Yang H, Jenni S, Čolović M et al (2017) 18F-5-Fluoroaminosuberic acid as a potential tracer to gauge oxidative stress in breast cancer models. J Nucl Med 58:367–373CrossRef Yang H, Jenni S, Čolović M et al (2017) 18F-5-Fluoroaminosuberic acid as a potential tracer to gauge oxidative stress in breast cancer models. J Nucl Med 58:367–373CrossRef
17.
Zurück zum Zitat Conrad M, Sato H (2012) The oxidative stress-inducible cystine/glutamate antiporter, system xc-: cystine supplier and beyond. Amino Acids 42:231–246CrossRef Conrad M, Sato H (2012) The oxidative stress-inducible cystine/glutamate antiporter, system xc-: cystine supplier and beyond. Amino Acids 42:231–246CrossRef
18.
Zurück zum Zitat Bridges RJ, Natale NR, Patel SA (2012) System xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol 165:20–34CrossRef Bridges RJ, Natale NR, Patel SA (2012) System xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol 165:20–34CrossRef
19.
Zurück zum Zitat Ishii T, Sato H, Miura K, Sagara J, Bannai S (1992) Induction of cystine transport activity by stress. Ann N Y Acad Sci 663:497–498CrossRef Ishii T, Sato H, Miura K, Sagara J, Bannai S (1992) Induction of cystine transport activity by stress. Ann N Y Acad Sci 663:497–498CrossRef
20.
Zurück zum Zitat Sasaki H, Sato H, Kuriyama-Matsumura K et al (2002) Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 277:44765–44771CrossRef Sasaki H, Sato H, Kuriyama-Matsumura K et al (2002) Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 277:44765–44771CrossRef
21.
Zurück zum Zitat Yang H, Tam B, Čolović M et al (2017) Addressing chirality in the structure and synthesis of [18F]5-fluoroaminosuberic acid ([18F]FASu). Chem Eur J 23:11100–11107CrossRef Yang H, Tam B, Čolović M et al (2017) Addressing chirality in the structure and synthesis of [18F]5-fluoroaminosuberic acid ([18F]FASu). Chem Eur J 23:11100–11107CrossRef
22.
Zurück zum Zitat Čolović M, Rousseau E, Zhang Z et al (2018) Synthesis and evaluation of an 18F-labeled boramino acid analog of aminosuberic acid for PET imaging of the antiporter system xC−. Bioorg Med Chem Lett 28:3579–3584CrossRef Čolović M, Rousseau E, Zhang Z et al (2018) Synthesis and evaluation of an 18F-labeled boramino acid analog of aminosuberic acid for PET imaging of the antiporter system xC−. Bioorg Med Chem Lett 28:3579–3584CrossRef
23.
Zurück zum Zitat Heiss P, Mayer S, Herz M et al (1999) Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 40:1367–1373PubMed Heiss P, Mayer S, Herz M et al (1999) Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 40:1367–1373PubMed
24.
Zurück zum Zitat Langen KJ, Hamacher K, Bauer D et al (2005) Preferred stereoselective transport of the D-isomer of cis-4-[18F]fluoro-proline at the blood-brain barrier. J Cereb Blood Flow Metab 25:607–616CrossRef Langen KJ, Hamacher K, Bauer D et al (2005) Preferred stereoselective transport of the D-isomer of cis-4-[18F]fluoro-proline at the blood-brain barrier. J Cereb Blood Flow Metab 25:607–616CrossRef
25.
Zurück zum Zitat Tsukada T, Sato K, Fukumoto D, Kakiuchi T (2006) Evaluation of D-isomers of O-18F-fluoromethyl, O-18F-fluoroethyl and O-18F-fluoropropyl tyrosine as tumour imaging agents in mice. Eur J Nucl Med Mol Imaging 33:1017–1024CrossRef Tsukada T, Sato K, Fukumoto D, Kakiuchi T (2006) Evaluation of D-isomers of O-18F-fluoromethyl, O-18F-fluoroethyl and O-18F-fluoropropyl tyrosine as tumour imaging agents in mice. Eur J Nucl Med Mol Imaging 33:1017–1024CrossRef
26.
Zurück zum Zitat Kersemans V, Cornelissen B, Kersemans K et al (2006) 123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice. Eur J Nucl Med Mol Imaging 33:919–927CrossRef Kersemans V, Cornelissen B, Kersemans K et al (2006) 123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice. Eur J Nucl Med Mol Imaging 33:919–927CrossRef
27.
Zurück zum Zitat Bauwens M, Keyaerts M, Lahoutte T, Kersemans K, Caveliers V, Bossuyt A, Mertens J (2007) Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine. Nucl Med Commun 28:823–828CrossRef Bauwens M, Keyaerts M, Lahoutte T, Kersemans K, Caveliers V, Bossuyt A, Mertens J (2007) Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine. Nucl Med Commun 28:823–828CrossRef
28.
Zurück zum Zitat Martarello L, McConathy J, Camp VM et al (2002) Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection. J Med Chem 45:2250–2259CrossRef Martarello L, McConathy J, Camp VM et al (2002) Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection. J Med Chem 45:2250–2259CrossRef
29.
Zurück zum Zitat Zhang Z, Liu S, Tang Z et al (2018) Radiosynthesis and preliminary biological evaluation of the 2-[18F]fluoropropionic acid enantiomers for tumor PET imaging. J Radioanal Nucl Chem 316:153–159CrossRef Zhang Z, Liu S, Tang Z et al (2018) Radiosynthesis and preliminary biological evaluation of the 2-[18F]fluoropropionic acid enantiomers for tumor PET imaging. J Radioanal Nucl Chem 316:153–159CrossRef
Metadaten
Titel
The Effect of Chirality on the Application of 5-[18F]Fluoro-Aminosuberic Acid ([18F]FASu) for Oxidative Stress Imaging
verfasst von
Milena Čolović
Hua Yang
Helen Merkens
Nadine Colpo
François Bénard
Paul Schaffer
Publikationsdatum
02.12.2019
Verlag
Springer International Publishing
Erschienen in
Molecular Imaging and Biology / Ausgabe 4/2020
Print ISSN: 1536-1632
Elektronische ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-019-01450-2

Weitere Artikel der Ausgabe 4/2020

Molecular Imaging and Biology 4/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.